Optimising management of chronic heart failure. [Lancet. 2009] - PubMed

loading

[Is it real to replace angiotensin converting enzyme inhibitors as basic remedy in the treatment of chronic heart failure?]. [Kardiologiia. 2002]
[Is it real to replace angiotensin converting enzyme inhibitors as basic remedy in the treatment of chronic heart failure?].
Mareev VIu. Kardiologiia. 2002; 42(12):4-12.
Are angiotensin II receptor blockers indicated in chronic heart failure? [Heart. 2002]
Are angiotensin II receptor blockers indicated in chronic heart failure?
Komajda M. Heart. 2002 Jan; 87(1):1-2.
[Current role of angiotensin II antagonists in the treatment of heart failure]. [Ital Heart J Suppl. 2000]
[Current role of angiotensin II antagonists in the treatment of heart failure].
Porcu M, Orrù P. Ital Heart J Suppl. 2000 Sep; 1(9):1213-4.
Review [Angiotensin-II-receptor antagonists for cardiac insufficiency]. [Internist (Berl). 2000]
Review [Angiotensin-II-receptor antagonists for cardiac insufficiency].
Kromer EP. Internist (Berl). 2000 Sep; 41(9):917-24.
Review Multiple renin-angiotensin-aldosterone-blocking agents in heart failure: how much is too much? [Curr Heart Fail Rep. 2009]
Review Multiple renin-angiotensin-aldosterone-blocking agents in heart failure: how much is too much?
Pitt B. Curr Heart Fail Rep. 2009 Jun; 6(2):112-6.

HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3. [PLoS One. 2011]
HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3.
Limana F, Esposito G, D'Arcangelo D, Di Carlo A, Romani S, Melillo G, Mangoni A, Bertolami C, Pompilio G, Germani A, et al. PLoS One. 2011; 6(6):e19845. Epub 2011 Jun 22.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Optimising management of chronic heart failure.
Optimising management of chronic heart failure.
Lancet. 2009 Nov 28 ;374(9704):1808-9. Epub 2009 Nov 16 .

PubMed
ABC transporter gene expression in benign and malignant ovarian tissue.
ABC transporter gene expression in benign and malignant ovarian tissue.
Gynecol Oncol. 2010 May ;117(2):198-201. Epub 2009 Nov 17 .

PubMed
Moz and retinoic acid coordinately regulate H3K9 acetylation, Hox gene expressio...
Moz and retinoic acid coordinately regulate H3K9 acetylation, Hox gene expression, and segment identity.
Dev Cell. 2009 Nov ;17(5):674-86.

PubMed
Morphogenesis: multitalented GTPases seeking new jobs.
Morphogenesis: multitalented GTPases seeking new jobs.
Curr Biol. 2009 Nov 17 ;19(21):R985-7.

PubMed
Solvent-assisted slow conversion of a dithiazole derivative produces a competiti...
Solvent-assisted slow conversion of a dithiazole derivative produces a competitive inhibitor of peptide deformylase.
Biochim Biophys Acta. 2010 Apr ;1804(4):704-13. Epub 2009 Nov 14 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed